Tag Archives: schizophrenia
Reasons Patients Doubt Medication-Resistant Delusions in Schizophrenia
Posted on05. Nov, 2010 by admin.
Most Patients Have Self-Doubt; CBT May Help By Icelini Garcia-Sosa, MD and Michael Garrett, MD Psychiatric Times | October 29, 2010 http://www.psychiatrictimes.com/schizophrenia/content/article/10168/1708863 Summary Most delusional patients, even those with high positive symptom scores, may have at least 1 Reason for Doubt (RFD) that precedes a clinical intervention specifically directed toward encouraging doubt. These preexisting “islands [...]
Continue Reading
Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial
Posted on03. Jun, 2010 by admin.
Wijnand Laan, PhD; Diederick E. Grobbee, MD, PhD; Jean-Paul Selten, MD, PhD; Cobi J. Heijnen, PhD; René S. Kahn, MD, PhD; and Huibert Burger, MD, PhD http://article.psychiatrist.com/dao_1-login.asp?ID=10006874&RSID=40173234257663 J Clin Psychiatry 2010;71(5):520–527 10.4088/JCP.09m05117yel © Copyright 2010 Physicians Postgraduate Press, Inc. Objective: Inflammatory processes may play a role in the pathophysiology of schizophrenia. The aim of this [...]
Continue Reading
Thinking Outside a Less Intact Box
Posted on01. Jun, 2010 by admin.
Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals Several lines of evidence support that dopaminergic neurotransmission plays a role in creative thought and behavior. Here, we investigated the relationship between creative ability and dopamine D2 receptor expression in healthy individuals, with a focus on regions where aberrations in dopaminergic [...]
Continue Reading
A Systemic Look At Schizophrenia
Posted on07. Mar, 2010 by admin.
FROM Chemical & Engineering News Serving the chemical, life sciences and laboratory worlds January 18, 2010 Background Because schizophrenia is a psychiatric disorder, its physical manifestations must all be in the brain, right? Maybe not. Proteomic studies using cells from other parts of the body are showing that there might be a systemic aspect of [...]
